Literature DB >> 23879644

Impact of geometric variations on delivered dose in highly focused single vocal cord IMRT.

Sarah O S Osman1, Eleftheria Astreinidou, Peter C Levendag, Ben J M Heijmen.   

Abstract

PURPOSE: To investigate the robustness of single vocal cord intensity modulated radiation therapy (IMRT) treatment plans for set-up errors, respiration, and deformation.
MATERIAL AND METHODS: Four-dimensional computed tomography (4D-CT) scans of 10 early glottic carcinoma patients, previously treated with conventional techniques, were used in this simulation study. For each patient a pre-treatment 4D-CT was used for IMRT planning, generating a reference dose distribution. Prescribed PTV dose was 66 Gy. The impact of systematic set-up errors was simulated by applying shifts of ± 2 mm to the planning CT scans, followed by dose re-calculation with original beam segments, MUs, etc. Effects of respiration and deformation were determined utilizing extreme inhale and exhale CT scans, and repeat scans acquired after 22 Gy, 44 Gy, and 66 Gy, respectively. All doses were calculated using Monte Carlo dose simulations.
RESULTS: Considering all investigated geometrical perturbations, reductions in the clinical target volume (CTV) V95%, D98%, D2%, and generalized equivalent uniform dose (gEUD) were limited to 1.2 ± 2.2%, 2.4 ± 2.9%, 0.2 ± 1.8%, and 0.6 ± 1.1 Gy, respectively. The near minimum dose, D98%, was always higher than 89%, and gEUD always remained higher than 66 Gy. Planned contra-lateral (CL) vocal cord DMean, gEUD, and V40 Gy were 38.2 ± 6.0 Gy, 43.4 ± 5.6 Gy, and 42.7 ± 14.9%. With perturbations these values changed by -0.1 ± 4.3 Gy, 0.1 ± 4.0 Gy, and -1.0 ± 9.6%, respectively.
CONCLUSIONS: On average, CTV dose reductions due to geometrical perturbations were very low, and sparing of the CL vocal cord was maintained. In a few observations (6 of 103 simulated situations), the near-minimum CTV-dose was around 90%, requiring attention in deciding on a future clinical protocol.

Entities:  

Mesh:

Year:  2013        PMID: 23879644     DOI: 10.3109/0284186X.2013.812793

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  4 in total

1.  Volumetric modulated arc radiotherapy of the whole larynx, followed by a single affected vocal cord, for T1a glottic cancer: Dosimetric analysis of a case.

Authors:  Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2016-01-14

2.  Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer.

Authors:  Young Suk Kim; Jaegi Lee; Jong In Park; Wonmo Sung; Sol Min Lee; Gwi Eon Kim
Journal:  Radiat Oncol J       Date:  2016-03-30

3.  Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial.

Authors:  Houda Bahig; David I Rosenthal; Félix-Phuc Nguyen-Tan; David C Fuller; Ying Yuan; Katherine A Hutcheson; Apostolos Christopoulos; Anthony C Nichols; Kevin Fung; Olivier Ballivy; Edith Filion; Sweet Ping Ng; Louise Lambert; Jennifer Dorth; Kenneth S Hu; David Palma
Journal:  BMC Cancer       Date:  2021-04-22       Impact factor: 4.430

4.  Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer.

Authors:  Chae-Seon Hong; Dongryul Oh; Sang Gyu Ju; Yong Chan Ahn; Jae Myoung Noh; Kwangzoo Chung; Jin Sung Kim; Tae-Suk Suh
Journal:  Cancer Res Treat       Date:  2015-03-06       Impact factor: 4.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.